Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.
byBenzinga Newsdesk
July 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Russia Boycotts Oscars: A Look Back At Previous Wins, Incuding One For An Anti-War Film

By Chris Katje
September 27, 1:43 PM
The 2023 Academy Awards is six months away, and Russia is already boycotting the show by refusing to submit a film to the International Feature category. The decision comes about seven months after Russian President Vladimir Putin initiated attacks on Ukraine. Since then, the U.S. has continued to provide support and military aid to Ukraine.

DIS